Literature DB >> 19397690

Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium.

H J Ankersmit1, K Hoetzenecker, W Dietl, A Soleiman, R Horvat, M Wolfsberger, C Gerner, S Hacker, M Mildner, B Moser, M Lichtenauer, B K Podesser.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) is followed by post AMI cardiac remodelling, often leading to congestive heart failure. Homing of c-kit+ endothelial progenitor cells (EPC) has been thought to be the optimal source for regenerating infarcted myocardium.
METHODS: Immune function of viable peripheral blood mononuclear cells (PBMC) was evaluated after co-culture with irradiated apoptotic PBMC (IA-PBMC) in vitro. Viable PBMC, IA-PBMC and culture supernatants (SN) thereof were obtained after 24 h. Reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay were utilized to quantify interleukin-8 (IL-8), vascular endothelial growth factor, matrix metalloproteinase-9 (MMP9) in PBMC, SN and SN exposed fibroblasts. Cell suspensions of viable- and IA-PBMC were infused in an experimental rat AMI model. Immunohistological analysis was performed to detect inflammatory and pro-angiogenic cells within 72 h post-infarction. Functional data and determination of infarction size were quantified by echocardiography and Elastica van Gieson staining.
RESULTS: The IA-PBMC attenuated immune reactivity and resulted in secretion of pro-angiogenic IL-8 and MMP9 in vitro. Fibroblasts exposed to viable and IA-PBMC derived SN caused RNA increment of IL-8 and MMP9. AMI rats that were infused with IA-PBMC cell suspension evidenced enhanced homing of endothelial progenitor cells within 72 h as compared to control (medium alone, viable-PBMC). Echocardiography showed a significant reduction in infarction size and improvement in post AMI remodelling as evidenced by an attenuated loss of ejection fraction.
CONCLUSION: These data indicate that infusion of IA-PBMC cell suspension in experimental AMI circumvented inflammation, caused preferential homing of regenerative EPC and replaced infarcted myocardium.

Entities:  

Mesh:

Year:  2009        PMID: 19397690     DOI: 10.1111/j.1365-2362.2009.02111.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  30 in total

1.  Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science.

Authors:  Lucian Beer; Michael Mildner; Hendrik Jan Ankersmit
Journal:  Ann Transl Med       Date:  2017-04

2.  Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.

Authors:  Alfred Gugerell; Dirk Sorgenfrey; Maria Laggner; Jürgen Raimann; Anja Peterbauer; Daniel Bormann; Susanne Suessner; Christian Gabriel; Bernhard Moser; Tobias Ostler; Michael Mildner; Hendrik J Ankersmit
Journal:  Blood Transfus       Date:  2019-02-21       Impact factor: 3.443

3.  Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size.

Authors:  Sonam Dilwali; Andrew Lysaght; Daniel Roberts; Fred G Barker; Michael J McKenna; Konstantina M Stankovic
Journal:  Otol Neurotol       Date:  2013-06       Impact factor: 2.311

4.  Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.

Authors:  K Hoetzenecker; A Assinger; M Lichtenauer; M Mildner; T Schweiger; P Starlinger; A Jakab; E Berényi; N Pavo; M Zimmermann; C Gabriel; C Plass; M Gyöngyösi; I Volf; H J Ankersmit
Journal:  Basic Res Cardiol       Date:  2012-08-17       Impact factor: 17.165

5.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Andrea Baumgartner; Matthias Hasun; Gregor Werba; Lucian Beer; Patrick Altmann; Georg Roth; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-03-17       Impact factor: 17.165

6.  Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.

Authors:  Michael Lichtenauer; Michael Mildner; Konrad Hoetzenecker; Matthias Zimmermann; Bruno Karl Podesser; Wolfgang Sipos; Ervin Berényi; Martin Dworschak; Erwin Tschachler; Mariann Gyöngyösi; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-09-28       Impact factor: 17.165

7.  Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia.

Authors:  Patrick Altmann; Michael Mildner; Thomas Haider; Denise Traxler; Lucian Beer; Robin Ristl; Bahar Golabi; Christian Gabriel; Fritz Leutmezer; Hendrik Jan Ankersmit
Journal:  F1000Res       Date:  2014-06-19

8.  High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells.

Authors:  Lucian Beer; Rudolf Seemann; Robin Ristl; Adolf Ellinger; Mohammad Mahdi Kasiri; Andreas Mitterbauer; Matthias Zimmermann; Christian Gabriel; Mariann Gyöngyösi; Walter Klepetko; Michael Mildner; Hendrik Jan Ankersmit
Journal:  BMC Genomics       Date:  2014-09-25       Impact factor: 3.969

9.  Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Gregor Werba; Lucian Beer; Konrad Hoetzenecker; Andrea Baumgartner; Matthias Hasun; Stefanie Nickl; Andreas Mitterbauer; Matthias Zimmermann; Mariann Gyöngyösi; Bruno Karl Podesser; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Secretome of peripheral blood mononuclear cells enhances wound healing.

Authors:  Michael Mildner; Stefan Hacker; Thomas Haider; Maria Gschwandtner; Gregor Werba; Caterina Barresi; Matthias Zimmermann; Bahar Golabi; Erwin Tschachler; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.